Cargando…
Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program
BACKGROUND: Coronavirus disease 2019 (COVID‐19) convalescent plasma (CCP) collection began in two Brazilian hospitals for treatment of severe/critical patients. METHODS AND MATERIALS: Mild/moderate COVID‐19 convalescents were selected as CCP donors after reverse transcription polymerase chain reacti...
Autores principales: | Wendel, Silvano, Kutner, Jose Mauro, Machado, Rafael, Fontão‐Wendel, Rita, Bub, Carolina, Fachini, Roberta, Yokoyama, Ana, Candelaria, Gabriela, Sakashita, Araci, Achkar, Ruth, Hamerschlak, Nelson, Scuracchio, Patricia, Amaral, Marcelo, Dal Ben, Mirian, Araujo, Danielle, Soares, Camila, Camargo, Anamaria, Kallás, Esper, Durigon, Edison, Reis, Luiz Fernando, Rizzo, Luiz Vicente |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756544/ https://www.ncbi.nlm.nih.gov/pubmed/32935877 http://dx.doi.org/10.1111/trf.16065 |
Ejemplares similares
-
Surrogate test performance for SARS‐CoV‐2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): How useful could they be?
por: Wendel, Silvano, et al.
Publicado: (2021) -
Longitudinal analysis of SARS‐CoV‐2 antibodies in 8000 U.S. first‐time convalescent plasma donations
por: Karbiener, Michael, et al.
Publicado: (2021) -
A novel competition ELISA for the rapid quantification of SARS‐CoV‐2 neutralizing antibodies in convalescent plasma
por: Wouters, Elise, et al.
Publicado: (2021) -
The 4-Year Experience with Implementation and Routine Use of Pathogen Reduction in a Brazilian Hospital
por: Fachini, Roberta Maria, et al.
Publicado: (2021) -
Convalescent plasma for covid19 – How long should a donor be excluded from donation?
por: Kutner, Jose M., et al.
Publicado: (2020)